Advertisement
U.S. markets closed

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
16.37+0.19 (+1.17%)
At close: 04:00PM EST
16.40 +0.03 (+0.18%)
After hours: 05:31PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.72B
Enterprise Value 2.21B
Trailing P/E 20.99
Forward P/E 22.73
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.92
Price/Book (mrq)4.72
Enterprise Value/Revenue 2.38
Enterprise Value/EBITDA 17.73

Trading Information

Stock Price History

Beta (5Y Monthly) 0.38
52-Week Change 3-25.99%
S&P500 52-Week Change 331.18%
52 Week High 332.59
52 Week Low 314.15
50-Day Moving Average 315.61
200-Day Moving Average 317.25

Share Statistics

Avg Vol (3 month) 31.34M
Avg Vol (10 day) 31.37M
Shares Outstanding 5166.39M
Implied Shares Outstanding 6166.39M
Float 8108.97M
% Held by Insiders 10.55%
% Held by Institutions 197.13%
Shares Short (Oct 31, 2024) 49.53M
Short Ratio (Oct 31, 2024) 48.43
Short % of Float (Oct 31, 2024) 47.74%
Short % of Shares Outstanding (Oct 31, 2024) 45.73%
Shares Short (prior month Sep 30, 2024) 47.98M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Sep 30, 2024

Profitability

Profit Margin 13.83%
Operating Margin (ttm)12.64%

Management Effectiveness

Return on Assets (ttm)8.72%
Return on Equity (ttm)27.36%

Income Statement

Revenue (ttm)929.24M
Revenue Per Share (ttm)5.62
Quarterly Revenue Growth (yoy)18.30%
Gross Profit (ttm)N/A
EBITDA 124.54M
Net Income Avi to Common (ttm)128.51M
Diluted EPS (ttm)0.78
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)565.33M
Total Cash Per Share (mrq)3.4
Total Debt (mrq)49.37M
Total Debt/Equity (mrq)8.55%
Current Ratio (mrq)2.29
Book Value Per Share (mrq)3.47

Cash Flow Statement

Operating Cash Flow (ttm)202.73M
Levered Free Cash Flow (ttm)221.72M